Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,601 signal articles · 137 in last 24h · 155,347 total before filter · latest 1h ago
137last 24h
852last 7d
146● bullish (7d)
90● bearish (7d)
214publishers
AllMacro192Earnings102M&A125Regulatory20Product22Analyst19
✕ clear all filterssentiment: bearishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Is Aptiv Underperforming the Nasdaq?
Barchart9d agobearish
Is Aptiv Underperforming the Nasdaq?

Despite Aptiv stock’s underperformance relative to the broader market over the past year, analysts remain strongly optimistic about the company’s future prospects.

The Case for Selling CrowdStrike Stock
Barchart9d agobearish
The Case for Selling CrowdStrike Stock

CrowdStrike remains one of the strongest growth stories in cybersecurity, with accelerating ARR, expanding customer adoption, and an enormous AI-security opportunity.

Lyft (LYFT) Stock Could Trade At A Discount Following Its 71% Fall
Simply Wall St.9d agobearish
Lyft (LYFT) Stock Could Trade At A Discount Following Its 71% Fall

Lyft has seen its share price fall to US$15.69 after a choppy stretch, and the question now is whether that level still lines up with what the business earns. The stock has dropped 71.2% over the past 5 years, which puts a lot of weight on whether the current earnings profile can support even today's slimmer valuation. Fresh developments around union representation for California drivers and a push into autonomous vehicle services can reshape Lyft's future cost structure and revenue mix,...

3 Stocks Under $50 That Fall Short
StockStory9d agobearish
3 Stocks Under $50 That Fall Short

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.

On Holding (ONON) Could Be 49% Undervalued After Its New FP Movement Drop
Simply Wall St.9d agobearish
On Holding (ONON) Could Be 49% Undervalued After Its New FP Movement Drop

On Holding (ONON) just announced a second limited-edition footwear collaboration with FP Movement, a product event that puts fresh attention on how this athletic brand is trying to connect with women buyers. For investors, this FP Movement tie-up lands after a tough stretch for the stock, with On Holding’s share price down about 17% over 30 days and roughly 29% over 90 days, while the 1-year total shareholder return has declined about 38%, which points to fading momentum despite fresh product...

Xcel Energy (XEL) Dropped, So What Is Catching Investors' Attention?
Simply Wall St.9d agobearish
Xcel Energy (XEL) Dropped, So What Is Catching Investors' Attention?

Xcel Energy (XEL) has recently drawn attention after outperforming the broader utility sector over the past year, partly linked to rising electricity demand and its ongoing clean-energy investment program. The recent retreat in Xcel Energy’s share price, with the stock down 8.44% over the past month and 6.42% over 90 days from a last close of US$72.49, contrasts with a 1-year total shareholder return of 3.65% and a 3-year total shareholder return of 37.04%. This indicates that near term...

How FTC Data‑Sharing Complaint And Investor Lawsuits At Hims & Hers Health (HIMS) Have Changed Its Investment Story
Simply Wall St.10d agobearish
How FTC Data‑Sharing Complaint And Investor Lawsuits At Hims & Hers Health (HIMS) Have Changed Its Investment Story

Hims & Hers Health has been hit with an FTC complaint and multiple securities class action lawsuits alleging improper sharing of sensitive health data and misleading billing practices, events that have already drawn regulatory scrutiny and legal pressure by mid‑2026. The allegations cut to the core of Hims & Hers’ telehealth model, putting its privacy assurances and subscription-based business practices under a spotlight that could reshape how it operates. Against this backdrop of FTC action...

Abbott Laboratories (ABT) Agrees To $385 Million Infant Formula Recall Settlement
Simply Wall St.10d agobearish
Abbott Laboratories (ABT) Agrees To $385 Million Infant Formula Recall Settlement

Abbott Laboratories (NYSE:ABT) reached a US$385 million settlement tied to the 2022 infant formula recall and Sturgis plant shutdown. The agreement resolves civil claims from families, states, and other plaintiffs alleging product safety failures and gaps in compliance with federal standards. The settlement follows U.S. Department of Justice and multi state investigations into Abbott's infant formula operations, with no admission of liability. This civil resolution of Abbott's 2022 formula...

Northrop Grumman (NOC) Stock May Be 21% Undervalued Following Sentinel Missile Progress
Simply Wall St.10d agobearish
Northrop Grumman (NOC) Stock May Be 21% Undervalued Following Sentinel Missile Progress

Northrop Grumman has had a mixed run, with the stock up 66.9% over the past 5 years but down so far this year, so investors are asking whether the current US$531.25 share price still lines up with the cash the business is expected to generate. Recent defense project milestones and contract decisions keep reshaping expectations for those future cash flows, which puts the valuation question front and center. A 66.9% gain over 5 years means anyone buying or holding Northrop Grumman today is...